The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
17h
Stockhead on MSNThe ASX players bringing new hope to IPF sufferersIdiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
Operator Welcome to BioNTech's fourth quarter and full year 2024 earnings call. I would like to hand the call over to Michael ...
Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch and urticaria activity with dupilumab, according to a poster presented here.
Mental health disorders in people with chronic obstructive pulmonary disease (COPD) are underdiagnosed and undertreated, leading to worsened symptoms and decreased quality of life, according to a new ...
--(BUSINESS WIRE)--Genentech, a member of the Roche Group ... respiratory tract infections including infections of the lungs, cold symptoms, and pain or swelling of the nose or throat viral ...
13d
Medpage Today on MSNRace-Neutral Asthma Assessment Better for Black ChildrenBy contrast, the 2022 GLI race-neutral equation identified two- to four-fold more Black children with asthma or symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results